BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sumida K, Molnar MZ, Potukuchi PK, George K, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Changes in Albuminuria and Subsequent Risk of Incident Kidney Disease. Clin J Am Soc Nephrol 2017;12:1941-9. [PMID: 28893924 DOI: 10.2215/CJN.02720317] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Nagai K, Yamagata K, Iseki K, Moriyama T, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T. Cause-specific mortality in the general population with transient dipstick-proteinuria. PLoS One 2019;14:e0223005. [PMID: 31577820 DOI: 10.1371/journal.pone.0223005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Koraishy FM, Hooks-Anderson D, Salas J, Rauchman M, Scherrer JF. Fast GFR decline and progression to CKD among primary care patients with preserved GFR. Int Urol Nephrol 2018;50:501-8. [PMID: 29404927 DOI: 10.1007/s11255-018-1805-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Nakamura T, Kawaguchi A. Phase 1 Studies to Define the Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Profiles of the Nonsteroidal Mineralocorticoid Receptor Antagonist Apararenone in Healthy Volunteers. Clin Pharmacol Drug Dev 2021;10:353-65. [PMID: 32820619 DOI: 10.1002/cpdd.855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zhang X, Bai R, Zou L, Zong J, Qin Y, Wang Y. Brachial-Ankle Pulse Wave Velocity as a Novel Modality for Detecting Early Diabetic Nephropathy in Type 2 Diabetes Patients. J Diabetes Res 2021;2021:8862573. [PMID: 33628837 DOI: 10.1155/2021/8862573] [Reference Citation Analysis]
5 Li J, Fagbote CO, Zhuo M, Hawley CE, Paik JM. Sodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing. Clin Kidney J 2019;12:620-8. [PMID: 31583087 DOI: 10.1093/ckj/sfz100] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Qian Q. Dietary Influence on Body Fluid Acid-Base and Volume Balance: The Deleterious "Norm" Furthers and Cloaks Subclinical Pathophysiology. Nutrients 2018;10:E778. [PMID: 29914153 DOI: 10.3390/nu10060778] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Park S, Woo J, Leem S, Heo NH, Cho N, Gil H, Kim JH, Lee EY. Transiently Observed Trace Albuminuria on Urine Dipstick Test Is Associated With All-Cause Death, Cardiovascular Death, and Incident Chronic Kidney Disease: A National Health Insurance Service-National Sample Cohort in Korea. Front Cardiovasc Med 2022;9:882599. [DOI: 10.3389/fcvm.2022.882599] [Reference Citation Analysis]
8 Kovesdy CP, Isaman D, Petruski-Ivleva N, Fried L, Blankenburg M, Gay A, Velentgas P, Folkerts K. Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study. Clin Kidney J 2021;14:1657-64. [PMID: 34084461 DOI: 10.1093/ckj/sfaa200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S175-84. [PMID: 34964873 DOI: 10.2337/dc22-S011] [Reference Citation Analysis]
10 Troost JP, Trachtman H, Spino C, Kaskel FJ, Friedman A, Moxey-Mims MM, Fine RN, Gassman JJ, Kopp JB, Walsh L, Wang R, Gipson DS. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis. Am J Kidney Dis 2021;77:216-25. [PMID: 32791086 DOI: 10.1053/j.ajkd.2020.04.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Márquez DF, Ruiz-Hurtado G, Segura J, Ruilope L. Microalbuminuria and cardiorenal risk: old and new evidence in different populations. F1000Res 2019;8:F1000 Faculty Rev-1659. [PMID: 31583081 DOI: 10.12688/f1000research.17212.1] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hellberg M, Höglund P, Svensson P, Clyne N. Randomized Controlled Trial of Exercise in CKD-The RENEXC Study. Kidney Int Rep 2019;4:963-76. [PMID: 31312771 DOI: 10.1016/j.ekir.2019.04.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
13 Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol 2019;7:115-27. [PMID: 30635225 DOI: 10.1016/S2213-8587(18)30313-9] [Cited by in Crossref: 89] [Cited by in F6Publishing: 50] [Article Influence: 29.7] [Reference Citation Analysis]
14 Zhong M, Yang YR, Zhang YZ, Yan SJ. Change in Urine Albumin-to-Creatinine Ratio and Risk of Diabetic Peripheral Neuropathy in Type 2 Diabetes: A Retrospective Cohort Study. Diabetes Metab Syndr Obes 2021;14:1763-72. [PMID: 33911889 DOI: 10.2147/DMSO.S303096] [Reference Citation Analysis]
15 Issa N, Vaughan LE, Denic A, Kremers WK, Chakkera HA, Park WD, Matas AJ, Taler SJ, Stegall MD, Augustine JJ, Rule AD. Larger nephron size, low nephron number, and nephrosclerosis on biopsy as predictors of kidney function after donating a kidney. Am J Transplant 2019;19:1989-98. [PMID: 30629312 DOI: 10.1111/ajt.15259] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
16 Pafundi PC, Garofalo C, Galiero R, Borrelli S, Caturano A, Rinaldi L, Provenzano M, Salvatore T, De Nicola L, Minutolo R, Sasso FC. Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects. Diagnostics (Basel) 2021;11:290. [PMID: 33673215 DOI: 10.3390/diagnostics11020290] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]